3DDENTISTRY LIMITED
Opportunity 76/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Sector-multiple EBITDA, turnover, and NAV-proxy valuation range with confidence tier — derived from extracted iXBRL financials.
Available from the Pro tier upwards.
See pricing →Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-07-31 | 2024-07-31 |
|---|---|---|
| Average employees | 1 | 100 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (15 events)Click to expand
- 2026-01-26📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-07-18📄change-person-director-company-with-change-dateofficers · CH01
- 2025-07-17📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2025-07-17📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2025-04-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-02-21📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-04-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-04-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-04-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-04-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-01-11📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-08-16📄change-account-reference-date-company-previous-extendedaccounts · AA01
- 2017-04-13🏢Company incorporatedAs 3DDENTISTRY LIMITED
- 2017-04-13➕PITT, David Julian Charles appointeddirector
- 2017-04-13📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Senior director age: Director aged approximately 63 — approaching natural succession window.
- +No director turnover: Company is 9 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primaryFounder aged 63+: Senior director is approximately 63. Approaching typical UK retirement age — succession thinking likely.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr David Julian Charles Pitt Individual · British · DOB 02/1963 · age 63 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 13/04/2017 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · CF postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A AND H PATH LTD→ 12476815 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| A BITE OF LIFE LIMITED→ 12481823 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| A C PATHOLOGY LIMITED→ 12285507 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| A CRAIG SOLUTIONS LTD→ 15751021 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AA IONESCU LTD→ 10729028 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AAPS SURGICAL LTD→ 15208180 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ABDULJABBAR HEALTHCARE LIMITED→ 15229469 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ABENDO LTD→ 15285854 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ABERGARW CARE HOME LIMITED→ 13118021 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| ABERTILLERY DC LTD→ 15584319 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ABJ CONSULTANTS LTD→ 17084063 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ABLOC HEALTH LTD→ 16104317 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.